NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia
· Delayed Price · Currency is AUD 0.105
+0.005 (5.00%)
Mar 10, 2026, 9:59 AM AEST
ASX:NSB Revenue
NeuroScientific Biopharmaceuticals had revenue of 317.91K AUD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 317.91K, down -85.63% year-over-year.
Revenue (ttm)
317.91K
Revenue Growth
-85.63%
P/S Ratio
104.61
Revenue / Employee
n/a
Employees
n/a
Market Cap
33.26M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Argenica Therapeutics | 1.01M |
| Algorae Pharmaceuticals | -26.16K |
| Avecho Biotechnology | 1.24M |
| EZZ Life Science Holdings | 61.40M |
| Entropy Neurodynamics | 1.58M |
| Proteomics International Laboratories | 3.21M |
| Noxopharm | 3.40M |
| Patrys | 100.38K |